Unknown

Dataset Information

0

Promising Multiple Sclerosis Agents In Late-Stage Development.


ABSTRACT: Developing drugs with enhanced safety profiles and improving treatment affordability are vital for patients with MS. The author reviews some encouraging new agents in late-stage development.

SUBMITTER: Kish T 

PROVIDER: S-EPMC6281141 | biostudies-other | 2018 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Promising Multiple Sclerosis Agents In Late-Stage Development.

Kish Troy T  

P & T : a peer-reviewed journal for formulary management 20181201 12


Developing drugs with enhanced safety profiles and improving treatment affordability are vital for patients with MS. The author reviews some encouraging new agents in late-stage development. ...[more]

Similar Datasets

| S-EPMC5614417 | biostudies-other
| S-EPMC10442480 | biostudies-literature
| S-EPMC8534278 | biostudies-literature
| S-EPMC2824956 | biostudies-other
| S-EPMC3024587 | biostudies-other
| S-EPMC4197902 | biostudies-other
| S-EPMC6324729 | biostudies-literature
| S-EPMC7922387 | biostudies-literature
| S-EPMC3677195 | biostudies-literature
| S-EPMC9019710 | biostudies-literature